Selectively binds to circulating VEGF, blockingVEGF's binding to its cell surface receptors,resulting in a reduction in tumour blood vesselmicrovascular development and thereby limitingblood flow to tumour tissues. The gene discussed is CD177; the disease is neoplasm.